How long does Granix (tbo-filgrastim) stay in your system?
Granix (tbo-filgrastim) is a short-acting, injectable form of filgrastim. After a dose, drug levels typically fall quickly and the medication’s effects on neutrophil counts track the dosing schedule rather than lasting for weeks.
The exact “how long it stays” in the body can vary by factors like kidney function, dosing frequency, and how your body clears the drug, but it is generally considered a medication with a relatively short duration of action.
When will Granix stop affecting blood counts after the last dose?
Clinically, Granix is used to maintain or raise neutrophil counts during periods of chemotherapy-related suppression. After stopping, neutrophil recovery and any related blood-count changes depend mainly on:
- your cancer/chemo regimen,
- your baseline marrow function,
- and the time since your last chemotherapy dose,
rather than a long lingering drug effect.
What factors can change how quickly it clears?
Your personal timeline can differ if you have:
- reduced kidney function (clearance can be slower for some drugs),
- changes in dosing frequency (more frequent dosing keeps levels up),
- other medications or medical conditions that affect metabolism and clearance.
Will Granix still show up on drug tests?
Standard drug screens are designed to detect common substances of abuse, not prescription biologic/immune-stimulating drugs like tbo-filgrastim. So Granix generally would not be expected to show up on typical workplace “drug tests.”
If you’re timing something (surgery, chemo, travel): what matters most?
For scheduling around Granix, clinicians usually focus on neutrophil response and chemotherapy timing rather than a precise “time in system.” If you tell me what you’re trying to time (for example, next chemo cycle, procedure, or side effects), I can tailor what to ask your prescriber or what typical guidance looks like.
Sources
- DrugPatentWatch.com: https://www.drugpatentwatch.com/